Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria

Annals of Clinical Biochemistry

Volumn 42, Issue 2, 2005, Pages 99-104

  Ozdemir, Gülsen ^a   Ozden, Meltem ^a   Maral, Hale ^a   Kuskay, Sevinc ^a   Cetinalp, Pinar ^a   Tarkun, Ilhan ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; MALONALDEHYDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; VASCULAR DISEASE;

ADULT; AGED; ALBUMINURIA; ANTIOXIDANTS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; VASCULAR DISEASES;

EID: 17144365092     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563053492838     Document Type: Article

References (31)

1. Brownlee M. Lilly Lecture 1993. Glycation and diabetic complications. Diabetes 1994; 43: 836-41
2. Kesavulu MM, Rao BK, Giri R, Vijaya J, Subramanyam G, Apparao C. Lipid peroxidation and antioxidant enzyme status in type 2 diabetics with coronary heart disease. Diabetes Res Clin Pract 2001; 53: 33-9
3. Inal M, Alata Ö. Erythrocyte superoxide dismutase activity and reduced glutathione level in patients with diabetes mellitus. Tracing J Med Sci 1994; 21: 9-11
4. Fujiwara Y, Kondo T, Murakami K, Kawakami Y. Decrease of the inhibition of lipid peroxidation by glutathione-dependent system in erythrocytes of non-insulin dependent diabetics. Klin Wochenschr 1989; 15; 67: 336-41
5. Sinclair AJ. Free radical mechanisms and vascular complications of diabetes mellitus. Diabetes Rev 1993; 2: 7-10
6. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 8; 340: 319-23
7. Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 1976; 57: 1079-82
8. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 11; 277: 1775-81
9. Stehouwer CD, Gall MA, Hougaard P, Jakobs C, Parving HH. Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria. Kidney Int 1999; 55: 308-14
10. Chico A, Perez A, Cordoba A, et al. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia 1998; 41: 684-93
11. The Expert Committee on the Diagnosis and Classification of Diabetes mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes mellitus. Diabetes Care 1998; 21(Suppl 1): 5-22
12. Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol 1979; 135: 372-6
13. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-69
14. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 61: 882-8
15. Kedziora-Kornatowska KZ, Luciak M, Blaszczyk J, Pawlak W. Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy. Nephrol Dial Transplant 1998; 13: 2829-32
16. Aydin A, Orhan H, Sayal A, Ozata M, Sahin G, Isimer A. Oxidative stress and nitric oxide related parameters in type Il diabetes mellitus: effects of glycemic control. Clin Biochem 2001; 34: 65-70
17. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 1996; 90: 255-60
18. Haffner SM, Agil A, Mykkanen L, Stern MP, Jialal I. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM. Diabetes Care 1995; 18: 646-53
19. Zukowska-Szczechowska E, Grzeszczak W, Lacka B. The role of oxidative stress in development of diabetic angiopathies. Wiad Lek 1998; 51: 35-9
20. Ceriello A, Bortolotti N, Motz E, et al. Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 1998; 21: 1529-33
21. Pfeifer PM, McCay PB. Reduced triphosphopyridine nucleotide oxidase-catalyzed alterations of membrane phospholipids. VI. Structural changes in mitochondria associated with inactivation of electron transport activity. J Biol Chem 1972; 10; 247: 6763-9
22. Jain SK. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J Biol Chem 1989; 15; 264: 21340-5
23. Collier A, Rumley A, Rumley AG, Paterson JR, Leach JP, Lowe GD, Small M. Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes 1992; 41: 909-13
24. Collier A, Wilson R, Bradley H, Thomson JA, Small M. Free radical activity in type 2 diabetes. Diabetes Med 1990; 7: 27-30
25. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997; 14; 157: 1413-8
26. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 4; 274: 1049-57
27. Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 1997; 51: 2-15
28. Deckert T, Kofoed-Enevoldsen A, Norgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen T. Microalbuminuria. Implications for micro- and macrovascular disease. Diabetes Care 1992; 15: 1181-91
29. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997; 4; 95: 1119-21
30. Tsai JC, Perrella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994; 5; 91: 6369-73
31. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 1996; 1; 98: 5-7